WeightWatchers’ stock soared on Tuesday after the company said it is getting into the prescription drug weight loss business with the acquisition of Sequence. Sequence is a telehealth provider that offers users access to drugs used to treat diabetes and obesity under such brand names as Ozempic, Wegovy and Trulicity.
